KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Gains from Investment Securities (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Gains from Investment Securities for 16 consecutive years, with $275.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 123.58% to $275.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $351.0 million, a 185.37% increase, with the full-year FY2025 number at $351.0 million, changed N/A from a year prior.
  • Gains from Investment Securities was $275.0 million for Q4 2025 at Bristol Myers Squibb, up from -$260.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $346.0 million in Q2 2025 to a low of -$269.0 million in Q3 2023.
  • A 5-year average of $27.4 million and a median of $18.0 million in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 772.5% in 2023, then soared 1404.35% in 2025.
  • Bristol Myers Squibb's Gains from Investment Securities stood at $327.0 million in 2021, then crashed by 113.46% to -$44.0 million in 2022, then soared by 690.91% to $260.0 million in 2023, then crashed by 52.69% to $123.0 million in 2024, then soared by 123.58% to $275.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Gains from Investment Securities are $275.0 million (Q4 2025), -$260.0 million (Q3 2025), and $346.0 million (Q2 2025).